SAGE Therapeutics Inc SAGE:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:02 PM EDT
37.67UNCH (UNCH)
Volume
18,046
Close
37.67quote price arrow down-0.83 (-2.16%)
Volume
238,934
52 week range
27.36 - 47.75
Loading...
  • Open38.42
  • Day High39.23
  • Day Low37.56
  • Prev Close38.50
  • 52 Week High47.75
  • 52 Week High Date11/04/21
  • 52 Week Low27.36
  • 52 Week Low Date05/09/22

Key Stats

  • Market Cap2.238B
  • Shares Out59.42M
  • 10 Day Average Volume0.40M
  • Dividend-
  • Dividend Yield-
  • Beta1.34
  • YTD % Change-11.45

KEY STATS

  • Open38.42
  • Day High39.23
  • Day Low37.56
  • Prev Close38.50
  • 52 Week High47.75
  • 52 Week High Date11/04/21
  • 52 Week Low27.36
  • 52 Week Low Date05/09/22
  • Market Cap2.238B
  • Shares Out59.42M
  • 10 Day Average Volume0.40M
  • Dividend-
  • Dividend Yield-
  • Beta1.34
  • YTD % Change-11.45

RATIOS/PROFITABILITY

  • EPS (TTM)-8.53
  • P/E (TTM)-4.42
  • Fwd P/E (NTM)-4.05
  • EBITDA (TTM)-506.70M
  • ROE (TTM)-29.31%
  • Revenue (TTM)6.17M
  • Gross Margin (TTM)88.58%
  • Net Margin (TTM)-8,162.17%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date10/31/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On SAGE Therapeutics Inc

 

Content From Our Affiliates

Profile

MORE
Sage Therapeutics, Inc. is a biopharmaceutical company that is focused on developing and commercializing medicines with debilitating disorders of the brain. The Company's product, ZULRESSO (brexanolone) CIV injection, is for the treatment of postpartum depression (PPD) in adults. It has a portfolio of other product candidates with a focus on modulating two central nervous system (CNS) receptor systems, GABA and NMDA. It targets diseases and disorders of the brain with three...
Kevin Starr
Non-Executive Independent Chairman of the Board
Barry Greene
President, Chief Executive Officer, Director
Kimi Iguchi
Chief Financial Officer, Treasurer
Address
215 1st St
Cambridge, MA
02142-1213
United States

Top Peers

SYMBOLLASTCHG%CHG
XENE
Xenon Pharmaceuticals Inc
35.91+0.38+1.07%
RLAY
Relay Therapeutics Inc
22.01-0.44-1.96%
RXDX
Prometheus Biosciences Inc
50.52-0.32-0.63%
AXSM
Axsome Therapeutics Inc
45.36-4.90-9.75%
ARVN
Arvinas Inc
43.66+1.60+3.80%